TrialClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Lower Respiratory Tract Infections Following Respiratory Syncytial Virus Monoclonal Antibody Nirsevimab Immunization Versus Placebo: Analysis From a Phase 3 Randomized Clinical Trial (MELODY).

Doug Arbetter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.